Prakt. lékáren. 2010; 6(5): 222-226

Hormone replacement therapy from the perspective of an endocrinologist

prof.MUDr.Josef Marek, CSc.
III. interní klinika 1. LF UK a VFN v Praze

Insufficient hormone production by the endocrine glands can be replaced either with identical hormones processed synthetically

(thyroid hormones, cortisol) or biotechnologically (growth hormone, gonadotropins) or with their synthetic analogues with improved

function (desmopressin; aldosterone, testosterone, oestrogen and progestin analogues). Due to the number of preparations, the options

to treat hormone deficiencies vary greatly. For the treatment of central diabetes insipidus, only one preparation by one company

is available; to treat growth hormone deficiency, seven analogical preparations by various companies are available; similar hormones

by three companies are available for the treatment of hypothyroidism; glucocorticoid deficiency is mainly treated with hydrocortison

tablets or injections and/or prednisone; aldosterone replacement is only possible with fludrocortison that is currently not registered

in this country; there is a wider choice in the case of testosterone deficiency in men and the widest range of preparations are available

for the treatment of oestrogen deficiency in women.

Keywords: desmopressin, growth hormone, thyroid hormones, adrenal hormones, testosterone analogues, oestrogens

Published: October 19, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marek J. Hormone replacement therapy from the perspective of an endocrinologist. Praktické lékárenství. 2010;6(5):222-226.
Download citation

References

  1. Marek J. Farmakoterapie endokrinních onemocnění a léčba kortikosteroidy. In: Marek J. (ed): Farmakoterapie vnitřních nemocí, 4. vydání. Praha: Grada, 2010: 343-394.
  2. Marek J, Řeřábek K. Hypotalamické a hypofyzární hormony. In: Suchopár J. (ed.): Remedia compendium, 4. vydání. Praha: Panax Co, 2009: 509-520.
  3. Límanová Z. Syndrom hypofunkce. In: Límanová Z (ed): Štítná žláza. Praha: Galén, 2006: 151-164.
  4. Broulík P. Farmakoterapie metabolických osteopatií. In: Marek J. (ed): Farmakoterapie vnitřních nemocí, 4. vydání. Praha: Grada, 2010: 417-438.
  5. Stárka L. Krizové situace při adrenálních endokrinopatiích. In: Zamrazil V, Pelikánová T, et al. Akutní stavy v endokrinologii a diabetologii. Praha: Galén, 2007: 69-83.
  6. Poršová-Dutoit I. Léčba mužského hypogonadismu. In: Poršová-Dutoit I. Mužský hypogonadismus. Praha: Jessenius Maxdorf, 2005: 104-121.
  7. Jeníček J. Hormonální substituční terapie a klimakterium. Praha: Grada, 2001: 101.
  8. Fait T, Šnajderová M, et al. Estrogenní deficit. Praha: Jessenius Maxdorf, 2007.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.